111 (YI) Cash & Current Investments (2017 - 2025)
111's (YI) quarterly Cash & Current Investments came in at $79.1 million in Q4 2025, up 9.67% year-on-year from $72.2 million in Q4 2024, and up 7.37% quarter-over-quarter from $73.7 million in Q3 2025.
111 (YI) Cash & Current Investments (2017 - 2025) Analysis & Trends
111 has disclosed Cash & Current Investments across 9 years of filings, most recently posting $79.1 million for Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $79.1 million, up 9.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $79.1 million (up 9.67% YoY), and the FY2025 annual result was $78.1 million, down 0.74% from the prior year.
- Cash & Current Investments came in at $79.1 million for Q4 2025 at 111, up from $73.7 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $24.4 billion in Q3 2021 to a low of $72.2 million in Q4 2024.
- The 5-year median for Cash & Current Investments is $105.3 million (2022), against an average of $2.3 billion.
- Across the five-year window, Cash & Current Investments jumped 13734.37% in 2021 and slumped 99.56% in 2022, its largest moves.
- 111's Cash & Current Investments stood at $119.0 million in 2021, then slipped by 15.29% to $100.8 million in 2022, then slipped by 14.07% to $86.6 million in 2023, then fell by 16.68% to $72.2 million in 2024, then advanced by 9.67% to $79.1 million in 2025.
- The last three Cash & Current Investments figures came in at $79.1 million (Q4 2025), $73.7 million (Q3 2025), and $9.1 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 176.23 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 3.98 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 2.18 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 3.94 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 138.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 336.88 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 15.00 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 79.14 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 2.16 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 2.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 79.14 Mn |
| Sep 30, 2025 | 73.71 Mn |
| Jun 30, 2025 | 9.14 Bn |
| Mar 31, 2025 | 86.38 Mn |
| Dec 31, 2024 | 72.16 Mn |
| Sep 30, 2024 | 80.43 Mn |
| Jun 30, 2024 | 73.70 Mn |
| Mar 31, 2024 | 87.29 Mn |
| Dec 31, 2023 | 86.60 Mn |
| Sep 30, 2023 | 109.86 Mn |
| Jun 30, 2023 | 5.10 Bn |
| Mar 31, 2023 | 5.15 Bn |
| Dec 31, 2022 | 100.78 Mn |
| Sep 30, 2022 | 106.73 Mn |
| Jun 30, 2022 | 103.83 Mn |
| Mar 31, 2022 | 118.28 Mn |
| Dec 31, 2021 | 118.98 Mn |
| Sep 30, 2021 | 24.35 Bn |
| Jun 30, 2021 | 170.56 Mn |
| Mar 31, 2021 | 168.45 Mn |